Cargando…
Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19
BACKGROUND: Testing is a principle component to reopening society and bringing the coronavirus 2019 (COVID-19) pandemic to an end. Pharmacists have the ability to perform certain point-of-care tests under federal regulations. On April 8, 2020, the Office of the Assistant Secretary for Health issued...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550092/ https://www.ncbi.nlm.nih.gov/pubmed/33132103 http://dx.doi.org/10.1016/j.japh.2020.10.003 |
_version_ | 1783592901651988480 |
---|---|
author | Uebbing, Emily Lacroix, Matthew Bratberg, Jeffrey Federico, Christopher |
author_facet | Uebbing, Emily Lacroix, Matthew Bratberg, Jeffrey Federico, Christopher |
author_sort | Uebbing, Emily |
collection | PubMed |
description | BACKGROUND: Testing is a principle component to reopening society and bringing the coronavirus 2019 (COVID-19) pandemic to an end. Pharmacists have the ability to perform certain point-of-care tests under federal regulations. On April 8, 2020, the Office of the Assistant Secretary for Health issued new guidance authorizing licensed pharmacists to order and administer COVID-19 tests. OBJECTIVE: The primary objective of this study was to investigate the views of pharmacists about pharmacist-ordered and -administered COVID-19 testing. METHODS: A 13-item questionnaire was developed to survey pharmacists who currently hold an active license in Rhode Island. RESULTS: A total of 122 (13.8%) pharmacists consented and responded to at least 1 question of the survey. The results indicated that the primary concern of the pharmacists in regard to performing COVID-19 testing was spreading the infection to family members (71.3%). Becoming personally infected (59.8%) and not having access to appropriate personal protective equipment (PPE) (62.3%) were the second and third most common concerns of the pharmacists. Almost all of the pharmacists (99.9%) responded that they would be willing to take part in the testing process if they had appropriate PPE. A total of 46% of the pharmacists expressed concern regarding reimbursement for their company, whereas 56% of the pharmacists requested personal compensation for this service. CONCLUSION: Expanding the pool of health care providers who can perform testing is critical to achieving and sustaining proposed testing thresholds. Rhode Island pharmacists are willing to take part in performing COVID-19 testing provided appropriate PPE is available and services are reimbursed. Pharmacists are the most accessible and essential health care providers willing to take on critically important roles during the COVID-19 pandemic provided appropriate safety measures can be met. |
format | Online Article Text |
id | pubmed-7550092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Pharmacists Association®. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75500922020-10-13 Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 Uebbing, Emily Lacroix, Matthew Bratberg, Jeffrey Federico, Christopher J Am Pharm Assoc (2003) Science and Practice BACKGROUND: Testing is a principle component to reopening society and bringing the coronavirus 2019 (COVID-19) pandemic to an end. Pharmacists have the ability to perform certain point-of-care tests under federal regulations. On April 8, 2020, the Office of the Assistant Secretary for Health issued new guidance authorizing licensed pharmacists to order and administer COVID-19 tests. OBJECTIVE: The primary objective of this study was to investigate the views of pharmacists about pharmacist-ordered and -administered COVID-19 testing. METHODS: A 13-item questionnaire was developed to survey pharmacists who currently hold an active license in Rhode Island. RESULTS: A total of 122 (13.8%) pharmacists consented and responded to at least 1 question of the survey. The results indicated that the primary concern of the pharmacists in regard to performing COVID-19 testing was spreading the infection to family members (71.3%). Becoming personally infected (59.8%) and not having access to appropriate personal protective equipment (PPE) (62.3%) were the second and third most common concerns of the pharmacists. Almost all of the pharmacists (99.9%) responded that they would be willing to take part in the testing process if they had appropriate PPE. A total of 46% of the pharmacists expressed concern regarding reimbursement for their company, whereas 56% of the pharmacists requested personal compensation for this service. CONCLUSION: Expanding the pool of health care providers who can perform testing is critical to achieving and sustaining proposed testing thresholds. Rhode Island pharmacists are willing to take part in performing COVID-19 testing provided appropriate PPE is available and services are reimbursed. Pharmacists are the most accessible and essential health care providers willing to take on critically important roles during the COVID-19 pandemic provided appropriate safety measures can be met. American Pharmacists Association®. Published by Elsevier Inc. 2021 2020-10-12 /pmc/articles/PMC7550092/ /pubmed/33132103 http://dx.doi.org/10.1016/j.japh.2020.10.003 Text en © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Science and Practice Uebbing, Emily Lacroix, Matthew Bratberg, Jeffrey Federico, Christopher Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title | Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title_full | Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title_fullStr | Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title_full_unstemmed | Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title_short | Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19 |
title_sort | pharmacists’ response during a pandemic: a survey on readiness to test during covid-19 |
topic | Science and Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550092/ https://www.ncbi.nlm.nih.gov/pubmed/33132103 http://dx.doi.org/10.1016/j.japh.2020.10.003 |
work_keys_str_mv | AT uebbingemily pharmacistsresponseduringapandemicasurveyonreadinesstotestduringcovid19 AT lacroixmatthew pharmacistsresponseduringapandemicasurveyonreadinesstotestduringcovid19 AT bratbergjeffrey pharmacistsresponseduringapandemicasurveyonreadinesstotestduringcovid19 AT federicochristopher pharmacistsresponseduringapandemicasurveyonreadinesstotestduringcovid19 |